IFNA8 / Unconjugated / 06

Product Details
Description This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human Interferon alpha-B / IFNA8 (rh Interferon alpha-B / IFNA8; Catalog#10347-H08H; NP_002161.2; Met1-Glu189). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography.
Conjugate Unconjugated
Clone 06
Target Species Human
Applications ELISA
Supplier Sino Biological
Catalog # Sign in to view product details, citations, and spectra
Size
Price
Antigen
Host
Isotype
About IFNA8
Predicted to enable cytokine activity and type I interferon receptor binding activity. Predicted to be involved in several processes, including B cell activation; lymphocyte activation involved in immune response; and positive regulation of peptidyl-serine phosphorylation of STAT protein. Predicted to act upstream of or within defense response to virus. Predicted to be located in extracellular region. Predicted to be active in extracellular space. [provided by Alliance of Genome Resources, Apr 2022]
Experiment Design Tools
Conjugation Options

Pair this antibody with compatibility secondary antibodies, and conjugation kits and services:

Panel Builders

Looking to design a Microscopy or Flow Cytometry experiment?

Validation References
Additional
Sources
Reviews & Ratings
Looking for more options?

111 IFNA8 antibodies from over 11 suppliers available with over 14 conjugates.

Supplier Page
 Compare